Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage
Externally Produced and Endorsed
Sponsor: Neurocritical Care Society
Publisher: Neurocritical Care, 2016
The use of antithrombotic agents, including anticoagulants, antiplatelet agents, and thrombolytics has increased over the last decade and is expected to continue to rise. Although antithrombotic-associated intracranial hemorrhage can be devastating, rapid reversal of coagulopathy may help limit hematoma expansion and improve outcomes.